Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 280-286

  Conner, James R ^a   Meserve, Emily ^a   Pizer, Ellen ^b   Garber, Judy ^a   Roh, Michael ^c   Urban, Nicole ^d   Drescher, Charles ^e   Quade, Bradley J ^a   Muto, Michael ^a   Howitt, Brooke E ^a   Pearlman, Mark D ^c   Berkowitz, Ross S ^a   Horowitz, Neil ^a   Crum, Christopher P ^a   Feltmate, Colleen ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CellNetix Pathology   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA; Fallopian; Ovarian cancer; Serous cancer

Indexed keywords

BRCA; FALLOPIAN; OVARIAN CANCER; SEROUS CANCER;

ADULT; AGED; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; OVARIECTOMY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84894038654     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.009     Document Type: Article

References (25)

1. Cancer facts and figures 2013 American Cancer Society Atlanta, Georgia, USA
2. J. Carlson, M.H. Roh, M.C. Chang, and C.P. Crum Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube Diagn Histopathol 14 8 2008 352 365
3. D.W. Kindelberger, Y. Lee, A. Miron, M.S. Hirsch, C. Feltmate, and F. Medeiros et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2 2007 161 169
4. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 1 2006 58 64
5. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2 2006 230 236
6. P.G. Rose, R. Shrigley, and G.L. Wiesner Germline BRCA2 mutation in a patient with fallopian tube carcinoma: a case report Gynecol Oncol 77 2 2000 319 320
7. P.J. Paley, E.M. Swisher, R.L. Garcia, S.N. Agoff, B.E. Greer, and K.L. Peters et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecol Oncol 80 2 2001 176 180
8. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 1 2005 127 132
9. B.A. Werness, S.J. Ramus, A.S. Whittemore, K. Garlinghouse-Jones, I. Oakley-Girvan, and R.A. Dicioccio et al. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations Hum Pathol 31 11 2000 1420 1424
10. B.A. Werness, S.J. Ramus, R.A. DiCioccio, A.S. Whittemore, K. Garlinghouse-Jones, and I. Oakley-Girvan et al. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry Int J Gynecol Pathol 23 1 2004 29 34
11. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, and A. Saleemuddin et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 1 2007 26 35
12. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 25 2007 3985 3990
13. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 1 2002 52 56
14. M.J. Mingels, T. Roelofsen, J.A. van der Laak, J.A. de Hullu, M.A. van Ham, and L.F. Massuger et al. Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls Gynecol Oncol 127 1 2012 88 93
15. R. Manchanda, A. Abdelraheim, M. Johnson, A.N. Rosenthal, E. Benjamin, and C. Brunell et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status BJOG 118 7 2011 814 824
16. S.N. Agoff, R.L. Garcia, B. Goff, and E. Swisher Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations Am J Surg Pathol 28 8 2004 1112 1114
17. J.G. Bijron, C.A. Seldenrijk, R.P. Zweemer, J.G. Lange, R.H. Verheijen, and P.J. van Diest Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis Am J Surg Pathol 37 8 2013 1123 1130
18. S.L. Wethington, K.J. Park, R.A. Soslow, N.D. Kauff, C.L. Brown, and F. Dao et al. Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) Int J Gynecol Cancer 23 9 2013 1603 1611
19. W. Reitsma, G.H. de Bock, J.C. Oosterwijk, J. Bart, H. Hollema, and M.J. Mourits Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens Eur J Cancer 49 1 2013 132 141
20. J. Liu, M.C. Cristea, P. Frankel, S.L. Neuhausen, L. Steele, and V. Engelstaedter et al. Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival Cancer Genet 205 1-2 2012 34 41
21. D.M. Hyman, Q. Zhou, A. Iasonos, R.N. Grisham, A.G. Arnold, and M.F. Phillips et al. Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer Cancer 118 15 2012 3703 3709
22. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation JAMA 296 2 2006 185 192
23. C.B. Powell, E.M. Swisher, I. Cass, J. McLennan, B. Norquist, and R.L. Garcia et al. Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy Gynecol Oncol 129 2 2013 364 371
24. C. Crum, M. Herfs, G. Ning, J. Bijron, B. Howitt, and C. Jimenez et al. Through the glass darkly: intraepithelial neoplasia, top-down differentiation and the road to ovarian cancer J Pathol 231 2013 402 412
25. J.M. Piek, B. Torrenga, B. Hermsen, R.H. Verheijen, R.P. Zweemer, and J.J. Gille et al. Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study Fam Cancer 2 2 2003 73 78